But the best option for a person with type 2 diabetes and heart disease should be decided with a clinician who can review the full picture
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines variants in appetite-regulation pathwaysincluding GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313that may help provide context about your genetic predisposition to respond to GLP-1 versus stimulant-based approaches
However, in murine models, exendin-4 demonstrates about 5,500-fold greater potency in improving glucose control, evidenced by the percentage fall in plasma glucose at 1 hour (87)
DAPA HF Trial In this trial 4,744 patients with New York Heart Association class II, III, or IV heart failure and an ejection fraction of 40% or less were randomized to receive either dapagliflozin 10 mg once daily or placebo for a median of 18.2 months (162)
Not do they cause cancer, but might they prevent it. And the real answer is: it depends
They also appear to decrease markers of systemic inflammation , which is critical because chronic inflammation fuels atherosclerosis (plaque buildup in arteries)